Extracellular matrix metalloproteinases inducer gene polymorphism and reduced serum matrix metalloprotease-2 activity in preeclampsia patients.

MLA

Amakye, Daniel, et al. “Extracellular Matrix Metalloproteinases Inducer Gene Polymorphism and Reduced Serum Matrix Metalloprotease-2 Activity in Preeclampsia Patients.” Experimental Biology and Medicine (Maywood, N.J.), vol. 248, no. 18, Sept. 2023, pp. 1550–55. EBSCOhost, https://doi.org/10.1177/15353702231199464.

APA

Amakye, D., Gyan, P. O., Santa, S., Aryee, N. A., Adu-Bonsaffoh, K., Quaye, O., & Tagoe, E. A. (2023). Extracellular matrix metalloproteinases inducer gene polymorphism and reduced serum matrix metalloprotease-2 activity in preeclampsia patients. Experimental Biology and Medicine (Maywood, N.J.), 248(18), 1550–1555. https://doi.org/10.1177/15353702231199464

Chicago

Amakye, Daniel, Priscilla O Gyan, Sheila Santa, Nii Ayite Aryee, Kwame Adu-Bonsaffoh, Osbourne Quaye, and Emmanuel Ayitey Tagoe. 2023. “Extracellular Matrix Metalloproteinases Inducer Gene Polymorphism and Reduced Serum Matrix Metalloprotease-2 Activity in Preeclampsia Patients.” Experimental Biology and Medicine (Maywood, N.J.) 248 (18): 1550–55. doi:10.1177/15353702231199464.